On Invalid Date, Opko Health (NASDAQ: OPK) reported Q2 2023 earnings per share (EPS) of -$0.03, up 78.57% year over year. Total Opko Health earnings for the quarter were -$19.64 million. In the same quarter last year, Opko Health's earnings per share (EPS) was -$0.14.
On Invalid Date, Opko Health (NASDAQ: OPK) reported Q2 2023 revenue of $265.42 million up 14.35% year over year. In the same quarter last year, Opko Health's revenue was $309.89 million.
What was OPK's revenue growth in the past year?
As of Q3 2023, Opko Health's revenue has grown -39.14% year over year. This is 41.05 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 1.91%. Opko Health's revenue in the past year totalled $868.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.